Table 3.
Measures | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 |
---|---|---|---|---|---|---|---|---|---|
1. Age | — | ||||||||
2. Months since LVAD implant | 0.16 | — | |||||||
3. PHQ-9 | −0.20* | 0.03 | — | ||||||
4. GAD-7 | −0.19 | 0.12 | 0.81*** | — | |||||
5. KCCQ QoL | 0.54*** | −0.03 | −0.57*** | −0.47*** | — | ||||
6. Return to function | 0.27** | −0.03 | −0.47*** | −0.42*** | 0.52*** | — | |||
7. Device-related distress | −0.32** | 0.07 | 0.48*** | 0.55*** | −0.45*** | −0.49*** | — | ||
8. Positive appraisal | 0.14 | −0.07 | −0.09 | −0.06 | 0.01 | 0.18 | −0.03 | — | |
9. Body image concerns | −0.22* | 0.06 | 0.28** | 0.27** | −0.26** | −0.39*** | 0.45*** | −0.11 | — |
10. FPAS total scores | .36*** | −0.08 | −0.50*** | −0.50*** | 0.47*** | 0.76*** | −0.78*** | 0.50*** | −0.65*** |
FPAS, Florida Patient Acceptance Survey; GAD-7, 7-item Generalized Anxiety Disorder; KCCQQoL, Kansas City Cardiomyopathy Questionnaire QoL; LVAD, Left Ventricular Assist Device; PHQ-9, 9-item Patient Health Questionnaire.
*p < 0.05 **p < 0.01 ***p < 0.001.